Onyvax, Cancer Research Campaign Technology, Institute of Cancer Research, Royal Marsden Hospital deal

The parties will identify genetic changes linked to the development and progression of prostate cancer to find drug targets. Onyvax will supply its cell immortalization technology to develop cell-line...